Juan A. García Meijide

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Juan A. García Meijide is an author at Pfizer (United States) specializing in inflammatory arthritis, rheumatoid arthritis pharmacotherapy, and pharmacology.

Publications per year

2012–2012

Publications

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen et al. · New England Journal of Medicine · 2012 · 939 citations · Full text

Medicine, Immunology, Pharmacology +13

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona Fleishaker, Juan A. García Meijide, Michael Kohen et al. · Arthritis Research & Therapy · 2012 · 68 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

1–2 of 2